EMR

Emerson Electric Co.
$136.69
-2.85 (-2.04%)
Mkt Cap 76.89B
Volume 917,484
52W Range 122.64-165.15
Sector Industrials
Beta 1.24
EPS (TTM) 4.35
P/E Ratio 31.56
Revenue (TTM) 18.32B
Rev Growth (5Y) +1.4%
EPS Growth (5Y) +4.5%
AlphaVal · Fair Value
What we estimate one share is worth
$105.12
Overvalued moderate signal
30.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
73.0 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 18.02B 17.49B 15.16B 13.80B 12.93B 16.79B 18.37B 17.41B 15.26B 14.52B 16.25B 17.73B
Net Income 2.29B 1.97B 13.22B 3.23B 2.30B 1.97B 2.31B 2.20B 1.52B 1.64B 2.71B 2.15B
EPS 4.07 3.44 3.75 4.63 3.85 3.26 3.74 3.49 2.36 2.54 4.02 3.07
Free Cash Flow 2.67B 2.91B 274.00M 2.39B 2.99B 2.54B 2.41B 2.27B 1.44B 2.43B 1.84B 2.92B
FCF / Share 4.74 5.10 0.48 4.03 5.01 4.22 3.91 3.60 2.24 3.78 2.74 4.18
Operating CF 3.10B 3.33B 637.00M 2.92B 3.58B 3.08B 3.01B 2.89B 1.91B 2.88B 2.53B 3.69B
Total Assets 41.96B 44.25B 42.75B 35.67B 24.71B 22.88B 20.50B 20.39B 19.59B 21.74B 22.09B 24.18B
Total Debt 13.76B 8.36B 8.71B 10.81B 7.23B 7.86B 5.72B 4.76B 4.66B 6.63B 6.84B 6.02B
Cash & Equiv 1.54B 3.59B 8.05B 1.80B 2.35B 3.31B 1.49B 1.09B 3.06B 3.18B 3.05B 3.15B
Book Value 20.28B 21.64B 20.69B 10.36B 9.88B 8.40B 8.23B 8.95B 8.72B 7.57B 8.08B 10.12B
Return on Equity 0.11 0.09 0.64 0.31 0.23 0.23 0.28 0.25 0.17 0.22 0.34 0.21
EMR News
Emerson Automates Refinery Scheduling to Improve Margins, Respond Faster to Market Volatility
Jul 16, 2026 05:00 AM · prnewswire.com
Emerson Schedules Third Quarter 2026 Earnings Release and Conference Call
Jul 14, 2026 12:15 PM · prnewswire.com
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
Jul 14, 2026 08:00 AM · gurufocus.com
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
Jul 14, 2026 08:00 AM · gurufocus.com
Emerson Electric (EMR) Declines More Than Market: Some Information for Investors
Jul 13, 2026 02:51 PM · zacks.com
Brokers Suggest Investing in Emerson Electric (EMR): Read This Before Placing a Bet
Jul 13, 2026 06:32 AM · zacks.com
Investors Heavily Search Emerson Electric Co. (EMR): Here is What You Need to Know
Jul 10, 2026 06:01 AM · zacks.com
Emerson Electric (EMR) Dips More Than Broader Market: What You Should Know
Jul 07, 2026 03:01 PM · zacks.com
4 Manufacturing Electronics Stocks to Consider on Promising Industry Trends
Jul 06, 2026 07:01 AM · zacks.com
Emerson Electric (EMR) Dips More Than Broader Market: What You Should Know
Jul 01, 2026 02:51 PM · zacks.com